Management Intravenous methylprednisolone 1,000 mg/day for 3 days, one dose of intravenous pulse cyclophosphamide 750 mg/m 2, intravenous immunoglobulin 400 mg/kg/day for 4 days, plasmapheresis on ...

CO: Cyclophosphamide and vincristine; EMA: Etoposide, methotrexate and actinomycin D; iv.: Intravenous. 1 Paclitaxel 135 mg/m 2 by iv. infusion over 3 h Cisplatin 60 mg/m 2 iv. infusion over 3 h ...

intravenous (IV) cyclophosphamide (CY) followed by azathioprine (AZA) as treatment for proliferative lupus nephritis. Patients and methods: Data for survival and kidney function were prospectively ...

Except for corticosteroids, the most available generic was 6 mg/ml paclitaxel injection (the availability was 82.9%), and the most available original brand was 200 mg cyclophosphamide injection powder ...

methylprednisolone 1000 mg daily × 3 days followed by high-dose oral glucocorticoids Addition of intravenous 'bolus' cyclophosphamide; use of intravenous γ-globulin; plasma exchange; rituximab?

Methods The BLISS trials compared belimumab 1 and 10 mg/kg versus placebo, all plus standard SLE therapy ... as well as patients treated with other biological agents or intravenous cyclophosphamide, ...

Becton Dickinson & Co. $232.97-12.09-4.93% ...

An open label study of 10 patients with proliferative nephritis (four WHO class III, six class IV) treated with standard ... requiring steroids plus cyclophosphamide or mycophenolate mofetil.

Derechos de autor © 2025 Yahoo. Todos los derechos reservados.

2-Year U.S. Treasury Note Continuous Contract $102.852-0.051-0.05% 5-Year U.S. Treasury Note Continuous Contract $106.688-0.172-0.16% 10-Year U.S. Treasury Note Continuous Contract $109.500-0.250 ...

Synopsis: A sugar-lipid molecule called OAcGD2 is a novel marker for breast cancer stem cells. Treatment with anti-OAcGD2 mAb8B6 may have superior anticancer efficacy by targeting cancer stem cells, ...